Request Information
Request Information
Founded in 2002 by Dr. Fred Moll, Hansen Medical pioneered the field of flexible robotic technology. Dr. Moll, a distinguished and prolific medical device entrepreneur, particularly in medical robotics, previously founded Intuitive Surgical and later founded Auris Health.
Hansen manufactured two robotic systems, the Magellan Robotic System and the Sensei Robotic System. The Magellan was built for multi-specialty, peripheral vascular robotics procedures and the Sensei for interventional electrophysiology procedures. In conjunction with the Sensei Robotic System, Hansen created the Artisan Extend Control Catheter, a robotically steerable sheath designed to enable catheter stability, reachability and contact force sensing when navigating third-party catheters in electrophysiology procedures. In March 2008, Frost & Sullivan presented Hansen Medical with the 2008 Product Innovation Award in the field of U.S. Image-Guided and Robotic-Assisted Surgery Devices.
In 2016, Auris Health acquired Hansen Medical, bringing a wealth of robotic technology and patents into the Auris portfolio. Following the Hansen integration, in March 2018, Auris Health launched the Monarch™ Platform, the first FDA-cleared robotic platform for diagnostic and therapeutic bronchoscopic procedures. The Monarch Platform is designed to allow physicians to diagnose small, hard-to-reach peripheral lung nodules with greater precision than ever before.
If you are a former Hansen Medical customer with questions, please contact us at:
Email: CustomerCare@aurishealth.com Phone: 1.800.434.0032
Learn more about Auris Health, Inc Learn more about the Monarch Platform
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.